6461.TWO
Price:
$15
Market Cap:
$2.46B
Intech Biopharm Corporation engages in developing and manufacturing generic drugs to treat respiratory diseases in Taiwan and internationally. It owns iLEF (inhaled low ethanol formulation), a metered dose inhaler platform for treating asthma and COPD; and dry powder inhaler, a product comprises of blisters and capsules. The company offers its products under the SYN006, SYN010, SYN007, Synflutide, Duasma, Synvent, and SYN011 names. Intech Biopharm Corporation was founded in 2010 and is headquartered in Taipei, Taiwan.
Industry
Biotechnology
IPO Date
2014-07-15
Stock Exchange
TWO
Ticker
6461.TWO
According to Intech Biopharm Corporation’s latest financial reports and current stock price. The company's current PE Ratio is -5.95. This represents a change of -49.13% compared to the average of -11.70 of the last 4 quarters.
The mean historical PE Ratio of Intech Biopharm Corporation over the last ten years is -7.86. The current -5.95 PE Ratio has changed 7.47% with respect to the historical average. Over the past ten years (40 quarters), 6461.TWO's PE Ratio was at its highest in in the March 2025 quarter at -8.48. The PE Ratio was at its lowest in in the June 2025 quarter at -19.18.
Average
-7.86
Median
-9.07
Minimum
-11.48
Maximum
0
Discovering the peaks and valleys of Intech Biopharm Corporation PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 70.19%
Maximum Annual PE Ratio = 0
Minimum Annual Increase = -Infinity%
Minimum Annual PE Ratio = -11.48
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -9.84 | -8.71% |
| 2023 | -10.78 | -6.04% |
| 2022 | -11.48 | 70.19% |
| 2021 | -6.74 | -18.65% |
| 2020 | -8.29 | -Infinity% |
The current PE Ratio of Intech Biopharm Corporation (6461.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-10.70
5-year avg
-9.43
10-year avg
-7.86
Intech Biopharm Corporation’s PE Ratio is less than Taiwan Bio Therapeutics Co., Ltd (-5.63), greater than TaiRx, Inc. (-17.86), greater than Steminent Biotherapeutics Inc. (-14.95), greater than Anti-Microbial Savior BioteQ Co., Ltd (-28.96), greater than GlycoNex Incorporation (-11.61), less than HeXun Biosciences Co., Ltd. (15.45), greater than Gwo Xi Stem Cell Applied Technology Co. , Ltd (-38.51), greater than Sunny Pharmtech Inc. (-7.79), greater than Sinew Pharma Inc. (-19.44), greater than Hcmed (-12.59),
| Company | PE Ratio | Market cap |
|---|---|---|
| -5.63 | $2.29B | |
| -17.86 | $2.54B | |
| -14.95 | $2.82B | |
| -28.96 | $2.62B | |
| -11.61 | $2.33B | |
| 15.45 | $2.56B | |
| -38.51 | $2.70B | |
| -7.79 | $2.10B | |
| -19.44 | $2.77B | |
| -12.59 | $2.29B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Intech Biopharm Corporation using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Intech Biopharm Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Intech Biopharm Corporation's PE Ratio?
How is the PE Ratio calculated for Intech Biopharm Corporation (6461.TWO)?
What is the highest PE Ratio for Intech Biopharm Corporation (6461.TWO)?
What is the 3-year average PE Ratio for Intech Biopharm Corporation (6461.TWO)?
What is the 5-year average PE Ratio for Intech Biopharm Corporation (6461.TWO)?
How does the current PE Ratio for Intech Biopharm Corporation (6461.TWO) compare to its historical average?